Uterine Artery Embolization and Pelvic Floor Symptoms

Withdrawn before enrolling

Conditions studied: Leiomyoma, Incontinence, Prolapse

In brief

The objective of this study is to determine whether women who are already receiving treatment for their fibroids (ie. UAE) demonstrate improvement in urinary symptoms and sexual dysfunction as well.

Key facts

Study ID

NCT00827645

Run by

University of Texas Southwestern Medical Center

People needed

0

Starts

2009-01-01

Expected to finish

2013-01-01

Last updated by the study team

2018-05-22

Who can join

Age: 18 and older, up to 80. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• female
• age 18-80 years
• symptomatic uterine fibroids
• scheduled for UAE
• Negative urine dipstick (negative result = trace or less for leukocytes \& nitrites) or negative UA or negative culture (Urine dipstick is performed as standard of care)
• Available for 12-months of follow-up and able to complete study assessments, per clinician judgment
• Signed consent form

You may not qualify if…

• Age <18 or >80 years
• women who are unable to read and write English,
• pregnancy or planned pregnancy in the next 12 months
• < 6 months postpartum
• current use of anticholinergic medication, cholinergic agonists, tricyclic antidepressants, or duloxetine - must have been off such drugs for at least 4 weeks
• women with surgery for urinary incontinence or pelvic organ prolapse in the past 6 months
• history of bladder or pelvic cancer or pelvic radiation therapy
• prior augmentation cystoplasty
• urethral diverticulum, current or repaired.

Where it is running

• University of Texas Southwestern Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.